Effect of a non biologic treat-totarget strategy on MRI-determined inflammatory and destructive changes in early rheumatoid arthritis. Results from af 2-year investigator-initiated double-blind randomized controlled clinical trial.

Signe Møller-Bisgaard, Bo Jannik Ejbjerg, Iris Eshed, Kim Hørslev-Petersen, Merete Lund Hetland, Anne Grethe Jurik, Jørgen Vallø, Henrik Thomsen, Trine Torfing, Kristian Stengaard-Pedersen, Peter Junker, Niels Steen Krogh, Tine Lottenburger, Torkell Ellingsen, Lis Smedegaard Andersen, Ib Hansen, Henrik Skjødt, Anders Jørgen Svendsen, Ulrik Tarp, Jan PødenphantJens Kristian Pedersen, Hanne Merete Lindegaard, Mikkel Ostergaard

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2015
Publication statusPublished - 2015
EventACR/ARHP: American College of Rheumatology - San Francisco, United States
Duration: 7. Nov 201511. Nov 2015

Conference

ConferenceACR/ARHP
Country/TerritoryUnited States
CitySan Francisco
Period07/11/201511/11/2015

Cite this